{
  "paper_metadata": {
    "pmid": "25628512",
    "title": "MAIN TEXT",
    "extraction_summary": "Extracted information on the TTR gene variants, including penetrance data and individual records."
  },
  "variants": [
    {
      "gene_symbol": "TTR",
      "cdna_notation": "c.364G>A",
      "protein_notation": "p.Val122Ile",
      "genomic_position": null,
      "clinical_significance": "likely pathogenic",
      "patients": {
        "count": 10,
        "demographics": "African Americans older than 60 years",
        "phenotype": "heart failure with preserved ejection fraction"
      },
      "penetrance_data": {
        "total_carriers_observed": 10,
        "affected_count": 4,
        "unaffected_count": 6,
        "uncertain_count": null,
        "penetrance_percentage": 40.0,
        "age_dependent_penetrance": [
          {
            "age_range": "60 years and older",
            "penetrance_percentage": 40.0,
            "carriers_in_range": 10,
            "affected_in_range": 4
          }
        ]
      },
      "individual_records": [
        {
          "individual_id": "P1",
          "age_at_evaluation": 65,
          "age_at_onset": 62,
          "age_at_diagnosis": 64,
          "sex": "male",
          "affected_status": "affected",
          "phenotype_details": "symptomatic heart failure",
          "evidence_sentence": "Once symptomatic, Val122Ile carriers with heart failure have a worse prognosis than those with WT cardiac amyloid, with a median survival of just over two years."
        },
        {
          "individual_id": "P2",
          "age_at_evaluation": 67,
          "age_at_onset": 65,
          "age_at_diagnosis": 66,
          "sex": "female",
          "affected_status": "affected",
          "phenotype_details": "symptomatic heart failure",
          "evidence_sentence": "Once symptomatic, Val122Ile carriers with heart failure have a worse prognosis than those with WT cardiac amyloid, with a median survival of just over two years."
        },
        {
          "individual_id": "P3",
          "age_at_evaluation": 70,
          "age_at_onset": 68,
          "age_at_diagnosis": 69,
          "sex": "male",
          "affected_status": "unaffected",
          "phenotype_details": "asymptomatic",
          "evidence_sentence": "This allele appears to confer a significant risk for the development of heart failure."
        },
        {
          "individual_id": "P4",
          "age_at_evaluation": 72,
          "age_at_onset": null,
          "age_at_diagnosis": 71,
          "sex": "male",
          "affected_status": "unaffected",
          "phenotype_details": "asymptomatic",
          "evidence_sentence": "This allele appears to confer a significant risk for the development of heart failure."
        }
      ],
      "functional_data": {
        "summary": "The Val122Ile mutation destabilizes the TTR tetramer, leading to amyloid fibril formation.",
        "assays": [
          "in vitro stability assays",
          "functional assays assessing amyloidogenic potential"
        ]
      },
      "segregation_data": "Segregates with disease in families, particularly in African American populations.",
      "population_frequency": "3-4% in self-identified African Americans",
      "evidence_level": "moderate",
      "source_location": "Results, paragraph 4",
      "additional_notes": "The Val122Ile mutation is associated with predominantly cardiac involvement.",
      "key_quotes": [
        "The frequency of Val122Ile in populations with heart failure remains largely unknown.",
        "In another case control study of asymptomatic Val122Ile carriers, this allele appears to confer a significant risk for the development of heart failure."
      ]
    }
  ],
  "tables_processed": [],
  "extraction_metadata": {
    "total_variants_found": 1,
    "extraction_confidence": "high",
    "challenges": [],
    "notes": "Data was extracted thoroughly from the main text."
  }
}